Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of MMED will - over the next 2 Weeks and hit - by . In that time frame, MMED's share price is expected to range between - and -.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No Data | |||||||||||||||||||
MMED shares fell -2.53% in Friday, May 15, 2026's trading session, dropping from a previous close of $11.08 to move at $10.80. The stock demonstrated notable intraday movement (see MMED's key stats for a full breakdown), fluctuating between $10.65 and $11.24, a +5.54% trading range. While recent weeks have seen some volatility, MMED has managed to secure a -9.01% drop over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 577.97K shares changing hands, 106.12K more than the previous session. This amounted to $6.24M in total market activity.
Will MMED Continue Its Trend?
According to analyst ratings and projections for MMED, MiniMed Group, Inc. Common Stock shares are anticipated to remain stable by -, potentially reaching - per share by January 1, 1970. Short-term technical indicators for MMED currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 18 negative trading days within the past 30 sessions. Based on the MMED stock forecast, now is not the best time to buy MMED stock because its current trading price is - our predicted value, hinting at a possible . For deeper insights, view our sentiment analysis on MMED covering social and institutional perspectives.
MMED Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into MMED's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 28.75% to 30.94%) suggest the stock is experiencing strong bearish momentum.Insights into MMED's shareholder base show how institutional investors are positioning themselves during these momentum shifts

